endothelial damage
[대역어] 내피 손상
[용어속성] Term
[용어속성] Term
Improvement of COVID‐ 19 with renal failure and paralytic ileus by using steroids
Case Report
[키워드] Acute kidney injury
acute respiratory syndrome
antiviral drugs
antivirals
Clinical course
Complication
Computed tomography
coronavirus
coronavirus disease
COVID‐19
COVID‐19
diagnosed
diarrhoea
disease
dominant
eight
endothelial damage
endothelial injury
Fever
Haemodialysis
Hemodialysis
High dose
hospital
improvement
intestine
management
multiple organ failure
nasal
paralytic ileus
Patient
polymerase chain
renal
Respiratory failure
RNA
SARS‐CoV‐2
steroid
Steroids
suffered
systemic
systemically
the patient
therapy
Vascular
[DOI] 10.1002/rcr2.689 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1002/rcr2.689 PMC 바로가기 [Article Type] Case Report
Endothelial Damage in Acute Respiratory Distress Syndrome
Review
[키워드] Activation
acute respiratory distress
ARDS
Biomarker
Biomarkers
blood vessel
cell damage
Coagulation
Coagulation system
Coronavirus disease-19
COVID-19
damage
dysfunction
effective
endothelial
Endothelial cell
endothelial damage
Endothelial dysfunction
endothelial injury
endotheliopathy
homoeostasis
hospitalised patient
Inflammation
involved
lung
morbidity and mortality
MOST
Pathogenesis
pathology
pharmacological treatment
Prognosis
Pulmonary endothelium
respiratory
Sepsis
syndrome
tested
Therapies
[DOI] 10.3390/ijms21228793 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijms21228793 PMC 바로가기 [Article Type] Review
Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty
Conference abstract
[키워드] Activation
acute phase reactants
Admission
affecting
analyzed
appear
Biomarker
Blood
board
Boehringer Ingelheim
certainty
chest imaging
circulating
clinical
collected
complement
Complication
Conjecture
contribute
Control
controls
coronavirus
Course
COVID-19
COVID-19 patient
COVID-19 patients
Critical
Culture
Degradation
detection
diagnostic
disease
download
dsDNA
elevated
ELISA test
endothelial
Endothelial cell
endothelial damage
endothelial function
endothelial injury
evaluated
figure
form
funding
healthy donor
Hoffmann-La Roche
Hospitalization
identify
immunofluorescence
Inflammatory
information
Injury
janssen
Jazz
Lancet
Level
marker
Mortality
multiple organs
Nasopharyngeal swab
NET
NETs
Neutrophil extracellular trap
no significant difference
non-critically ill patient
non-infectious
not differ
notable
Novartis
pathophysiology
Patient
plasma
Pneumonia
positive
potentially life-threatening
prognostic
protein C
pulmonary complication
radiological
reduced
responsible
Result
Science
Septic shock
Sharp
Siemens Healthineers
significantly
significantly higher
significantly increased
significantly lower
speaker
Stress
syndrome
systemic inflammatory response
Takeda
the disease
therapeutic intervention
Therapeutics
thrombotic
vWF
were assessed
were measured
were used
[DOI] 10.1182/blood-2020-142311 [Article Type] Conference abstract
[DOI] 10.1182/blood-2020-142311 [Article Type] Conference abstract
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
COVID-19의 내피 손상 및 혈전성 미세혈관병증: 렉틴 경로 억제제 나르소플리맙으로 치료
Article
[키워드] activate
Activation
acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
Adverse drug reaction
Adverse drug reactions
anticoagulant effects
ARDS
Arterial thrombosis
Autopsies
baseline
bind
C-reactive protein
C-reactive protein (CRP
circulating
compassionate use
complement
Complement activation
complications
Continuous Positive Airway Pressure
control group
Coronavirus-2
COVID-19
COVID-19 patient
CPAP
CRP
during treatment
effective
Endothelial cell
endothelial cell damage
endothelial damage
endothelial injury
enzyme
human immunoglobulin
IgG4
IL-6
IL-8
Immunoglobulin
Inflammation
inhibit
inhibitor
Injury
interleukin
interleukin-6
interleukin-8
intubation
Lactate
lactate dehydrogenase
LDH
lectin
lectin pathway
life-threatening
Lung injury
mannan
MASP-2
monoclonal antibody
Mortality
Narsoplimab
nucleocapsid protein
pathogenic
Patient
positive airway pressure
reducing
reduction
reported
respiratory
respiratory distress
Respiratory distress syndrome
resulting
retrospective
SARS-CoV-2
Serine
serine protease
serum
Serum IL-6
Serum level
serum levels
Severe acute respiratory syndrome
severe acute respiratory syndrome-associated coronavirus-2
significantly higher
survived
sustained
syndrome
thrombosis
thrombotic
thrombotic event
Thrombotic events
thrombotic risk
treat
Treatment
treatment for COVID-19
was used
were assessed
were used
[DOI] 10.1016/j.imbio.2020.152001 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.imbio.2020.152001 PMC 바로가기 [Article Type] Article
Hyperthrombotic Milieu in COVID-19 Patients
Review
[키워드] alteration
cascade
clinically
Coagulation
coagulation cascade
Coagulopathy
component
coronary syndrome
coronavirus
COVID-19
COVID-19 infection
develop
dominant
Embolism
endothelial cell damage
endothelial damage
endotheliopathy
events
Evidence
experience
extrinsic
fibrinolytic
implication
Kidney failure
marker
mechanism
Microvascular thrombosis
milieu
Mortality
Multisystem organ failure
Myocardial infarction
nuance
Occurrence
Outbreaks
parameter
patients
patients with COVID-19
predictor
probe
Respiratory failure
risk
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
shown
stroke
strokes
systemic anticoagulation
systemic manifestations
the patient
therapeutic targets
therapy
Thromboembolic event
Thromboprophylaxis
thrombosis
triggered
venous
venous thromboembolic
VTE
while
widespread
with COVID-19
[DOI] 10.3390/cells9112392 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/cells9112392 PMC 바로가기 [Article Type] Review
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Article
[키워드] activate
Activation
acute respiratory syndrome
Alternative pathway
animal
antibody
APC
Atypical
blocked
C3c
catastrophic
cells
clinical manifestation
complement
Complement pathway
contagious
coronavirus
COVID-19
Direct
disease
end-organ
end-organ damage
endothelial damage
Evidence
explain
Human
Hypothesis
in vitro
inactivation
Injury
killing
mechanism
mice
mitigate
Myocardial infarction
Prevent
renal
respiratory virus
SARS-CoV-2
SARS-CoV-2 spike protein
SARS-CoV-2 spike proteins
Spike protein
stroke
subunit
supernatant
syndrome
target cells
the N protein
the SARS-CoV-2
thrombosis
Trigger
upstream
uremic syndrome
[DOI] 10.1182/blood.2020008248 PMC 바로가기 [Article Type] Article
[DOI] 10.1182/blood.2020008248 PMC 바로가기 [Article Type] Article
More than Pneumonia: Distinctive Features of SARS-Cov-2 Infection. From Autopsy Findings to Clinical Implications: A Systematic Review
Review
[키워드] Acute kidney injury (AKI)
acute respiratory distress
acute respiratory distress syndrome (ARDS)
alveolar
ARDS
Autopsies
Autopsy
autopsy study
bronchopneumonia
Case series
clinical
clinical feature
Comorbidity
Complete
contributed
COVID-19
COVID-19 disease
Cytokine storm
dataset
death
died
diffuse alveolar damage (DAD)
disease
endothelial damage
Features
finding
gold standard
histopathological features
inclusion criteria
Infection
Inflammatory
management
Microthrombosis
multiple organ failure
pathogen
patients with COVID-19
Post-mortem
producing
provided
recommendation
Research
resulting
retrospective
review
subject
syndrome
systematic review
Therapeutic approach
Thromboembolism
was performed
with COVID-19
[DOI] 10.3390/microorganisms8111642 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/microorganisms8111642 PMC 바로가기 [Article Type] Review
Host–Viral Interactions Revealed among Shared Transcriptomics Signatures of ARDS and Thrombosis: A Clue into COVID-19 Pathogenesis
Original Article
[키워드] Activation
acute respiratory distress
Anticoagulant
ARDS
Biotechnology
Coagulation
coagulation factor
Combination
conducted
Convolution
COVID-19
COVID-19 pathogenesis
COVID-19 patients
database
dataset
datasets
DEGs
DHX9
differentially expressed gene
disease
effect size
endothelial damage
enrichment analysis
expression data
Gene Expression
Helicase
highly pathogenic
host–virus interaction
implication
IMPROVE
Infection
Inflammation
KAT2B
low molecular weight
lung
lysine
management
mechanism
Meta-analysis
NCBI-GEO
network
novel corona virus
observation
Pathway enrichment analysis
Pathways
Protein
PSMB2
random effect
RBX1
RELA
Replication
Revealed
SARS-CoV-2
Sepsis
shown
signature
subsequent
subunit
suggested
syndrome
Therapeutic strategies
thrombosis
thrombotic
TP53
transcriptomics
Treatment
Venous Thromboembolism
virus
VTE
was done
was used
were used
worsened
[DOI] 10.1055/s-0040-1721706 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1055/s-0040-1721706 PMC 바로가기 [Article Type] Original Article
Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19
혈관신생, 유전성 출혈성 모세혈관확장증 및 COVID-19
Case Reports
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus-2
ACVRL1
Adult patients
Angiogenesis
characterized
Clinical course
Clinical data
coronavirus disease
Coronavirus disease 2019
Coronavirus disease 2019 (COVID-19)
COVID-19
COVID-19 patient
COVID-19 pneumonia
discharged
disease
endothelial damage
endothelial injury
Epistaxis
Evidence
Hemorrhagic
Hereditary
Hereditary hemorrhagic telangiectasia
investigator
mechanical ventilation
multicenter
open
pathogenic
pathogenic variant
pathologic
Patient
patients
Pneumonia
Prevalence
provoke
rare disease
rare diseases
registry
respiratory
SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
telangiectasia
Vascular
worsening
[DOI] 10.1007/s10456-020-09755-5 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1007/s10456-020-09755-5 PMC 바로가기 [Article Type] Case Reports